Issuing the first license for a factory that develops software and medical applications in the Kingdom

The Food and Drug General Authority has announced the granting of the first license to a factory specialized in developing software and medical applications in the Kingdom, and this comes within the results of the initiative of licensing medical programs in the field of digital health, which it launched during the World Health Forum 2024. The factory has been introduced by an innovative medical device that depends on the diagnosis of foot symptoms Diabetes in its early stages using thermal imaging technology and analysis of images through advanced software, and the device has passed all the necessary clinical studies adopted by the authority.

The authority emphasized that this step reflects its commitment to support the development of the medical devices industry, in line with the Kingdom’s 2030 vision and keeping pace with all technical developments in various fields of work, in order to encourage innovation and innovators in the field of advanced medical devices and supplies.